Xin-Hai. Pei, et.al., Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis., Cancer research, 2011, 71

http://rdf.ncbi.nlm.nih.gov/pubmed/21487039

Xin-Hai. Pei, et.al., Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis., Cancer research, 2011, 71

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Cul9<tm1.1Yxi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5007735
• Cul9<tm1.2Yxi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5007737

class

http://purl.org/net/cito/citesAsAuthority

• Cul9<tm1.1Yxi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5007735
• Cul9<tm1.2Yxi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5007737

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0012431I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• premature death_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9tm12YxiTgIghMyc22Bri0Cul9tm12YxiTgIghMyc22Bri
• decreased cellular sensitivity to gamma-irradiation_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0003207I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased pituitary gland tumor incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0010320I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• decreased body weight_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0001262I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased tumor incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0002020I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• increased ovary tumor incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0008000I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• decreased cell proliferation_Trp53<tm1Tyj>/Trp53<tm1Tyj>
  http://metadb.riken.jp/0000352I129S2SvPasC57BL6Trp53tm1TyjTrp53tm1TyjTrp53tm1Tyj
• increased lung tumor incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0008014I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0012431I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9TgIghMyc22Bri0TgIghMyc22BriCul9Cul9tm12Yxi
• decreased cellular sensitivity to ultraviolet irradiation_Trp53<tm1Tyj>/Trp53<tm1Tyj>
  http://metadb.riken.jp/0008411I129S2SvPasC57BL6Trp53tm1TyjTrp53tm1TyjTrp53tm1Tyj
• increased tumor incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0002020I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased liver tumor incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0008019I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased lung tumor incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0008014I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• increased insulinoma incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0003364I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• decreased cellular sensitivity to ultraviolet irradiation_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0008411I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• premature death_Cul9<tm1.2Yxi>/Cul9<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9TgIghMyc22Bri0TgIghMyc22BriCul9Cul9tm12Yxi
• increased incidence of tumors by chemical induction_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0004499I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• increased incidence of tumors by chemical induction_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0004499I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0012431I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• increased B cell derived lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9tm12YxiTgIghMyc22Bri0Cul9tm12YxiTgIghMyc22Bri
• increased sarcoma incidence_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0002032I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• premature death_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0002083I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• altered tumor pathology_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0010639I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9tm12YxiTgIghMyc22Bri0Cul9tm12YxiTgIghMyc22Bri
• altered tumor pathology_Cul9<tm1.2Yxi>/Cul9<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0010639I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9TgIghMyc22Bri0TgIghMyc22BriCul9Cul9tm12Yxi
• premature death_Cul9<tm1.2Yxi>/Cul9<+>
  http://metadb.riken.jp/0002083I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9Cul9tm12YxiCul9
• increased lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0012431I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9tm12YxiTgIghMyc22Bri0Cul9tm12YxiTgIghMyc22Bri
• increased pituitary gland tumor incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0010320I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi
• increased B cell derived lymphoma incidence_Cul9<tm1.2Yxi>/Cul9<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023I129P2OlaHsdC57BLC57BL6FVBNSJLCul9tm12YxiCul9TgIghMyc22Bri0TgIghMyc22BriCul9Cul9tm12Yxi
• increased sarcoma incidence_Cul9<tm1.2Yxi>/Cul9<tm1.2Yxi>
  http://metadb.riken.jp/0002032I129P2OlaHsdC57BL6FVBNCul9tm12YxiCul9tm12YxiCul9tm12Yxi